ETFs With Biogen Idec Inc (BIIB) Exposure
The following ETFs maintain significant exposure to Biogen Idec Inc (BIIB); each of the following funds counts BIIB among its top ten individual holdings. Note that percentages in the table reflect weightings at the beginning of the current month, and are subject to change.
To see a complete breakdown of any of the ETFs included in the table below, including sector, market cap, and country allocations, click on the ticker symbol.
|Ticker||ETF||ETFdb Category||Expense Ratio||Weighting|
|BBH||Market Vectors Biotech ETF||Health & Biotech Equities||0.35%||9.43%|
|IBB||Nasdaq Biotechnology||Health & Biotech Equities||0.48%||7.45%|
|FBT||NYSE Arca Biotechnology Index Fund||Health & Biotech Equities||0.60%||5.65%|
|PBE||Dynamic Biotech &Genome||Health & Biotech Equities||0.60%||4.62%|
|QQXT||NASDAQ-100 Ex-Technology Sector Index||Large Cap Growth Equities||0.60%||2.22%|
|RYH||S&P Equal Weight Health Care ETF||Health & Biotech Equities||0.50%||1.90%|
|QQEW||NASDAQ-100 Equal Weighted Index Fund||Large Cap Growth Equities||0.60%||1.27%|
|FTC||Large Cap Growth AlphaDEX Fund||Large Cap Growth Equities||0.70%||1.19%|
|QQQE||NASDAQ-100 Equal Weighted Index Shares||Large Cap Growth Equities||0.35%||1.06%|
|FAD||Multi Cap Growth AlphaDEX Fund||All Cap Equities||0.70%||0.60%|
|FEX||Large Cap Core AlphaDEX Fund||Large Cap Blend Equities||0.70%||0.53%|
© 2013 Morningstar, Inc. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.